Serum hyaluronic acid in chronic viral hepatitis B and C: a biomarker for assessing liver fibrosis in chronic hemodialysis patients
- 30 May 2015
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 47 (7) , 1209-1217
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- End‐stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infectionJournal of Viral Hepatitis, 2012
- Transient Elastography to Assess Hepatic Fibrosis in Hemodialysis Chronic Hepatitis C PatientsClinical Journal of the American Society of Nephrology, 2011
- The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis CKidney International, 2010
- Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection†Hepatology, 2007
- Transient elastography for patients with chronic hepatitis B and C virus infection: Non‐invasive, quantitative assessment of liver fibrosisHepatology Research, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Performance of serum marker panels for liver fibrosis in chronic hepatitis CJournal of Hepatology, 2006
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CHepatology, 2004
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology, 2003
- Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPSKidney International, 2003